Related Experiment Videos
Biochemistry of bacterial type I DNA topoisomerases
1Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla 10595.
Advances in Pharmacology (San Diego, Calif.)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of phosphorothioate substitutions on DNA cleavage by Escherichia coli DNA topoisomerase I.
International journal of biological macromolecules·2001
The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change.
The Journal of biological chemistry·2000
Increased sensitivity to oxidative challenges associated with topA deletion in Escherichia coli.
Journal of bacteriology·2000
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026
Rethinking osteocyte models in vitro: the need for mineralised extracellular matrix and network architecture.
Frontiers in bioengineering and biotechnology·2026
Bioinductive collagen scaffolds for partial- and full-thickness rotator cuff repair: a systematic review.
Clinics in shoulder and elbow·2026
A Biomimetic Nasal Mucus Gel System Adaptable for Catalytic Antibacterial Therapy.
Small (Weinheim an der Bergstrasse, Germany)·2026